Osaic Holdings’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.2K | Sell |
2,611
-1,137
| -30% | -$30.6K | ﹤0.01% | 4427 |
|
|
2025
Q1 | $103K | Buy |
3,748
+1,298
| +53% | +$35.7K | ﹤0.01% | 4133 |
|
|
2024
Q4 | $66.1K | Buy |
2,450
+250
| +11% | +$6.74K | ﹤0.01% | 4481 |
|
|
2024
Q3 | $63.4K | Buy |
2,200
+425
| +24% | +$12.3K | ﹤0.01% | 4552 |
|
|
2024
Q2 | $48.4K | Sell |
1,775
-573
| -24% | -$15.6K | ﹤0.01% | 4681 |
|
|
2024
Q1 | $65.8K | Sell |
2,348
-505
| -18% | -$14.1K | ﹤0.01% | 4525 |
|
|
2023
Q4 | $75.9K | Sell |
2,853
-2,011
| -41% | -$53.5K | ﹤0.01% | 4608 |
|
|
2023
Q3 | $124K | Sell |
4,864
-382
| -7% | -$9.77K | ﹤0.01% | 4338 |
|
|
2023
Q2 | $137K | Sell |
5,246
-900
| -15% | -$23.6K | ﹤0.01% | 4200 |
|
|
2023
Q1 | $161K | Buy |
6,146
+183
| +3% | +$4.8K | ﹤0.01% | 4048 |
|
|
2022
Q4 | $164K | Buy |
5,963
+5
| +0.1% | +$137 | ﹤0.01% | 4033 |
|
|
2022
Q3 | $142K | Hold |
5,958
| – | – | ﹤0.01% | 4060 |
|
|
2022
Q2 | $158K | Buy |
5,958
+33
| +0.6% | +$875 | ﹤0.01% | 4017 |
|
|
2022
Q1 | $217K | Sell |
5,925
-1,702
| -22% | -$62.3K | ﹤0.01% | 3962 |
|
|
2021
Q4 | $207K | Sell |
7,627
-1,061
| -12% | -$28.8K | ﹤0.01% | 3907 |
|
|
2021
Q3 | $224K | Buy |
8,688
+80
| +0.9% | +$2.06K | ﹤0.01% | 3803 |
|
|
2021
Q2 | $223K | Sell |
8,608
-1,719
| -17% | -$44.5K | ﹤0.01% | 3774 |
|
|
2021
Q1 | $264K | Buy |
10,327
+695
| +7% | +$17.8K | ﹤0.01% | 3492 |
|
|
2020
Q4 | $248K | Buy |
9,632
+2,785
| +41% | +$71.7K | ﹤0.01% | 3275 |
|
|
2020
Q3 | $165K | Buy |
6,847
+4,615
| +207% | +$111K | ﹤0.01% | 3413 |
|
|
2020
Q2 | $50K | Buy |
2,232
+141
| +7% | +$3.16K | ﹤0.01% | 4167 |
|
|
2020
Q1 | $41K | Buy |
+2,091
| New | +$41K | ﹤0.01% | 4104 |
|